Marvin Herzberger
Marvin Herzberger is a publishing trader at TraderFox GmbH and group leader for the technical analysis of the DAX. He has been actively engaged in technical analysis since 2011. In this context, he has tested, analyzed, and evaluated various trading strategies in practical implementation. His area of expertise lies in swing trading. The analyses cover a short-term time horizon of up to 10 days.
Latest from Marvin Herzberger
TeraWulf: The Billion-Dollar Infrastructure Transformation for the AI Sector - Morgan Stanley Raises Price Target to $65!
The focus on high-performance computing (HPC) and AI infrastructure fundamentally expands the business...
Teva Pharmaceuticals: Schizophrenia Treatment Without Monitoring Requirements Gains U.S. Market Access
Teva is increasingly focusing on specialty medications and aims for up to $16.8 billion in revenue...
GoDaddy: Beyond the acquisition fantasy, the company has even more to offer with its realignment toward the "Agentic Open Web"!
At the end of September, GoDaddy (GDDY) (i.) came back into the spotlight for investors due to takeover...
Andritz: New Insights on Medium-Term Goals from Capital Markets Day!
The Andritz AG is becoming an essential substance stock for the energy transition. At the recent Capital...
Vir Biotechnology: FDA Fast Track Status and New Clinical Data as Potential Price Drivers - Barclays Sets Target at $30!
Vir Biotechnology (VIR) focuses on combating infectious diseases and cancer through the human immune...
GlobalFoundries: Agreement with TSMC to Establish US Manufacturing of Silicon Interposers for Advanced AI Packaging!
GFS will manufacture silicon interposers for AI chips in the USA for TSMC. The agreement alleviates...
Chevron: Potential $45 Billion Industry Relief from the US Environmental Protection Agency and its Impact on the Permian Strategy
The 4% rise in oil prices and the prospect of loosening methane regulations in the US are driving Chevron's...
Unity Software: Deal with Google attracts attention in the gaming industry - Emerging AI gaming market in focus!
Unity Software benefits from a far-reaching collaboration with Google for AI-driven game development....
Chewy Inc.: Analysts from Morgan Stanley see 100% price potential in the subscription model!
Morgan Stanley confirms the buy recommendation for Chewy Inc. (CHWY) with a price target of $36, supported...
Redcare Pharmacy: For me, the forecast upgrade was a buying trigger!
Redcare Pharmacy (i.) is on a strong growth path thanks to the digitization of the German healthcare...
ServiceNow: Bundesliga Partnership Reinforces AI Focus in CRM!
ServiceNow drives growth through AI solutions and aims for an AI contract value of $1.5 billion by...
Charles River Laboratories: Digital Boost through Apollo Orchestrate and New Long-Term Goals
The company aims for an annual organic revenue growth of 5 to 7% from 2027 to 2030, as well as an operating...
Compass Inc.: Anywhere Merger Sparks New Market Enthusiasm - Barclays Sees 70% Price Potential
The technology-based business model of Compass Inc. (COMP) significantly benefits from market consolidation...
Vistra: Nuclear Power as the Key to the Energy Hunger of the AI Era - Experts See a Further 34% Price Potential!
Transformation: Vistra establishes itself as a strategic energy partner through the AI boom. Current...
Genmab: Oncology Specialist Breaks Out to Multi-Year High After Study Data - I Expect Further Price Increases!
Genmab (i.) is a European healthcare stock that combines the development of its own antibody technologies...
GameStop: Insider Purchases as Preparation for the Next Squeeze?
The GameStop stock (GME) has recently come back into the spotlight for speculative investors. Notably,...
Ondas: Drone Defense and Acquisitions Drive the Value of the Autonomy Platform - Citizens Announces $14 Price Target!
Citizens Research has Ondas Inc. (ONDS) initiated coverage on October 5 with an "Outperform" rating...
Vaxcyte: Phase 3 Success for VAX-31: Protection Against 31 Bacterial Strains Causes Stock to Rise by 50%
Vaxcyte targets prevention markets with protein conjugates. OPUS-1 data confirm the efficacy of VAX-31...
Thermo Fisher Scientific: Strategic Realignment and Margin Growth!
Thermo Fisher Scientific's diversified business model benefits from structural trends in biopharmaceutical...
Union Pacific: Norfolk Southern Integration Restructures U.S. Freight Network!
Union Pacific's business model increasingly focuses on the expansion into a transcontinental U.S. railroad...